DrugPatentWatch Database Preview

CENTANY Drug Profile

« Back to Dashboard

When do Centany patents expire, and when can generic versions of Centany launch?

Centany is a drug marketed by Perrigo New York and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in CENTANY is mupirocin. There are fourteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.

Summary for CENTANY

US Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	2
Bulk Api Vendors:	58
Clinical Trials:	1
Patent Applications:	4,417
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CENTANY
DailyMed Link:	CENTANY at DailyMed

Pharmacology for CENTANY

Drug Class	RNA Synthetase Inhibitor Antibacterial
Mechanism of Action	RNA Synthetase Inhibitors

Medical Subject Heading (MeSH) Categories for CENTANY

Anti-Bacterial Agents

Protein Synthesis Inhibitors

Synonyms for CENTANY

(E)-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-Epoxy-5-hydroxy-4-methylhexyl)tetrahydro-3,4-dihydroxy-beta-methyl-2H-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid

115074-43-6

12650-69-0

1jzs

5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S)

5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S)]]-L-talonon-2-enonic acid 8-carboxyoctyl ester

6-Chloro-2,4-dimethoxy pyrimidine

62916-63-6

8-Carboxyoctyl (E)-4-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylcrotonat

80558-54-9

9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic acid

9-((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)-tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid

9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)-oxiranylmethyl]-tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)-nonanoic acid

9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid calcium salt

9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt

9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid

9-(4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)-tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid

9-(4-{3,4-Dihydroxy-5-[3-(2-hydroxy-1-methyl-propyl)-oxiranylmethyl]-tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)-nonanoic acid (Mupirocin)

9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid

9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methyl-propyl]oxiran-2-yl]methyl]tetrahydropyran-2-yl]-3-methyl-but-2-enoyl]oxynonanoic acid

9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid

9-{[(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-{[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl}oxan-2-yl]-3-methylbut-2-enoyl]oxy}nonanoic acid

AB0010371

AB01563109_01

AC1L9JV4

AKOS015994756

AOB6353

AS-11580

Bactoderm

Bactroban

Bactroban (TN)

Bactroban Nasal

Bactroban Ointment

BC656995

BDBM50290686

BIDD:GT0320

BRL 4910A

BRL-4910A

C11758

C26H44O9

CAS-12650-69-0

CCG-213522

Centany (TN)

CHEBI:7025

CHEBI:94519

CHEMBL719

cid_446596

CPD000471888

D01076

D03JSJ

D0GX863OA5

DB00410

DR003067

DSSTox_CID_26438

DSSTox_GSID_46438

DSSTox_RID_81614

DTXSID0046438

HMS2234E20

HMS3259L05

HY-B0958

KS-5137

LP070857

LS-177887

M-8680

M2955

MFCD01711620

MFCD11977847

MINDHVHHQZYEEK-HBBNESRFSA-N

MLS001074711

MolPort-003-666-882

MRC

Mupirocin

Mupirocin (USP/INN)

Mupirocin [USAN:USP:INN:BAN]

Mupirocin calcium

mupirocin calcium salt

mupirocin lithium salt

Mupirocin Neo-Sensitabs

Mupirocin, >=92% (HPLC), powder

Mupirocin, 14C-Labeled

Mupirocin, Antibiotic for Culture Media Use Only

Mupirocin, Pseudomonic Acid A

Mupirocin, United States Pharmacopeia (USP) Reference Standard

Mupirocina

Mupirocina [Spanish]

Mupirocine

Mupirocine [French]

Mupirocinum

Mupirocinum [Latin]

mupricin

NC00620

NCGC00164554-03

Nonanoic acid, 9-((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-, (2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))-

NSC-759182

NSC759182

Pharmakon1600-01505706

Plasimine

Pseudomonic acid

Pseudomonic acid A

Pseudomonic acid A lithium salt

S4297

SAM002589979

SBI-0206892.P001

SC-16672

SCHEMBL1027618

SCHEMBL3291

SMR000471888

Tox21_112183

trans-Pseudomonic acid

Turixin

UNII-D0GX863OA5

ZINC4102194

US Patents and Regulatory Information for CENTANY

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Perrigo New York	CENTANY	mupirocin	OINTMENT;TOPICAL	050788-001	Dec 4, 2002	BX	RX	No	No			Y

Expired US Patents for CENTANY

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Perrigo New York	CENTANY	mupirocin	OINTMENT;TOPICAL	050788-001	Dec 4, 2002

International Patents for CENTANY

Country	Document Number	Estimated Expiration
Germany	69900561
Spain	2165723
Israel	123143
Canada	2259764
European Patent Office	0933081